LEUKOCYTE DEPLETION IN LABILE BLOOD PRODUCTS

被引：0
|
作者：
GEROTA, J
CAVALIER, J
MASSE, M
WALLER, W
BIDET, ML
机构：
[1] CTR NATL TRANSFUS SANGUINE, F-91943 LES ULIS, FRANCE
[2] CTR REG TRANSFUS BESANCON, BESANCON, FRANCE
[3] CTR REG TRANSFUS STRASBOURG, F-67085 STRASBOURG, FRANCE
[4] CTR REG TRANSFUS ANGERS, F-49021 ANGERS, FRANCE
来源：
REVUE FRANCAISE DE TRANSFUSION ET IMMUNO-HEMATOLOGIE | 1987年 / 30卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：109 / +
页数：1
相关论文
共 50 条
  • [31] EFFECTS OF LEUKOCYTE DEPLETION ON THE FORMATION OF ANAPHYLATOXINS IN STORED WHOLE-BLOOD
    SCHLEUNING, M
    UTZ, H
    HEIM, M
    MEMPEL, W
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1992, 19 (05): : 242 - 244
  • [32] Persistence of HTLV-I in blood components after leukocyte depletion
    Pennington, J
    Taylor, GP
    Sutherland, J
    Davis, RE
    Seghatchian, J
    Allain, JP
    Williamson, LM
    BLOOD, 2002, 100 (02) : 677 - 681
  • [33] LEUKOCYTE-POOR BLOOD PRODUCTS - FILTRATION MECHANISMS
    STENEKER, I
    VOX SANGUINIS, 1994, 67 : 159 - 160
  • [34] Current data on the counting of weak leucocyte concentrations of labile blood products
    Masse, M
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1995, 2 (05) : 365 - 372
  • [35] Pathogen inactivation in labile blood products transfusion safety and economic impact
    Cazenave, Jean-Pierre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2006, 190 (01): : 169 - 185
  • [36] Qualitative and quantitative aspects of the use of the labile blood products in french Guyana
    Dzierzek, A. -C.
    Kallel, H.
    Marciniak, B.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2014, 33 : A345 - A345
  • [37] Computer assisted prescription of labile blood products: What are we expecting?
    Daurat, G.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2016, 23 (04) : 192 - 195
  • [38] Hepatitis G virus and labile blood products:: role of transfusional transmission
    Merle, P
    Elghouzzi, MH
    Pradat, P
    Vidal, F
    Boiret, E
    Trépo, C
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2004, 11 (02) : 75 - 80
  • [39] Evaluation of actual traceability of labile blood products from patients' records
    Ingrand, P
    Salmi, LR
    Benz-Lemoine, E
    Dupuis, M
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1998, 5 (06) : 397 - 407
  • [40] Labile natural products
    Wakimoto, Toshiyuki
    Abe, Ikuro
    MEDCHEMCOMM, 2012, 3 (08) : 866 - 870
12345